title: An MS patient loses trust when she finds out her doctor is paid by drug companies.
authors.affiliation: University of Minnesota, Minneapolis, Minnesota, USA. wols0016@umn.edu
authors.forename: Maran
authors.initials: M
authors.lastname: Wolston
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D030881:Disclosure / Q000941:ethics; D004345:Drug Industry / Q000941:ethics*; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008910:Minnesota; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D058991:Patient Protection and Affordable Care Act; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects*; D010820:Physicians / Q000191:economics* / Q000941:ethics*; D014481:United States
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000069442:Natalizumab; D010455:Peptides; D000068717:Glatiramer Acetate